WO2012123924A3 - Composition antimicrobienne - Google Patents

Composition antimicrobienne Download PDF

Info

Publication number
WO2012123924A3
WO2012123924A3 PCT/IB2012/051280 IB2012051280W WO2012123924A3 WO 2012123924 A3 WO2012123924 A3 WO 2012123924A3 IB 2012051280 W IB2012051280 W IB 2012051280W WO 2012123924 A3 WO2012123924 A3 WO 2012123924A3
Authority
WO
WIPO (PCT)
Prior art keywords
antimicrobial
antimicrobial composition
aggregation
composition including
silver particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2012/051280
Other languages
English (en)
Other versions
WO2012123924A2 (fr
Inventor
Robert Hutchings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OOSTERLAAK Neil
Original Assignee
OOSTERLAAK Neil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OOSTERLAAK Neil filed Critical OOSTERLAAK Neil
Priority to AP2013007143A priority Critical patent/AP2013007143A0/xx
Publication of WO2012123924A2 publication Critical patent/WO2012123924A2/fr
Publication of WO2012123924A3 publication Critical patent/WO2012123924A3/fr
Anticipated expiration legal-status Critical
Priority to ZA2013/07018A priority patent/ZA201307018B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dermatology (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition antimicrobienne présentant des propriétés antimicrobiennes et une activité vis-à-vis de, entre autres, la tuberculose (TB), la malaria et le cancer. Plus particulièrement, mais non exclusivement, la présente invention concerne une composition antimicrobienne présentant une activité antimicrobienne, utile dans le traitement et la prévention d'infections, de maladies et/ou de troubles. La présente invention concerne en outre des procédés de préparation de la composition antimicrobienne et l'utilisation de ladite composition dans la fabrication de préparations antimicrobiennes pour le traitement et/ou la prévention d'infections, de maladies et/ou de troubles.
PCT/IB2012/051280 2011-03-16 2012-03-16 Composition antimicrobienne Ceased WO2012123924A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AP2013007143A AP2013007143A0 (en) 2011-03-16 2012-03-16 Antimicrobial composition
ZA2013/07018A ZA201307018B (en) 2011-03-16 2013-09-18 Antimicrobial composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA201101612 2011-03-16
ZA2011/01612 2011-03-16

Publications (2)

Publication Number Publication Date
WO2012123924A2 WO2012123924A2 (fr) 2012-09-20
WO2012123924A3 true WO2012123924A3 (fr) 2013-06-06

Family

ID=45937484

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2012/051280 Ceased WO2012123924A2 (fr) 2011-03-16 2012-03-16 Composition antimicrobienne

Country Status (3)

Country Link
AP (1) AP2013007143A0 (fr)
WO (1) WO2012123924A2 (fr)
ZA (1) ZA201307018B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2675692C1 (ru) * 2017-08-18 2018-12-21 Дамир Зиннатович Хабибуллин Способ воздействия на микобактерии туберкулеза в эксперименте in vitro
US11896612B2 (en) 2019-03-29 2024-02-13 Board Of Trustees Of Michigan State University Resurrection of antibiotics that MRSA resists by silver-doped bioactive glass-ceramic particles
CN115414360A (zh) * 2022-08-30 2022-12-02 上海交通大学医学院附属仁济医院 全反式维甲酸联合抗生素在治疗假体周围感染中的应用
CN118649180B (zh) * 2024-07-12 2025-11-07 陕西科技大学 一种滴眼液及其制备方法及应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060090598A1 (en) * 2004-11-03 2006-05-04 Goia Dan V Aqueous-based method for producing ultra-fine silver powders
US20060264518A1 (en) * 2003-04-28 2006-11-23 Kenji Kato Method for preparing liquid colloidal dispersion of silver particles, liquid colloidal dispersion of silver particles, and silver conductive film
JP2008001961A (ja) * 2006-06-23 2008-01-10 Fujifilm Corp 金属微粒子分散物、着色組成物、感光性転写材料、遮光画像付き基板、カラーフィルタ、及び表示装置
JP2009019235A (ja) * 2007-07-11 2009-01-29 Toda Kogyo Corp 銀ナノ粒子の水性分散液およびその製造方法
JP2009030111A (ja) * 2007-07-27 2009-02-12 Sumitomo Metal Mining Co Ltd 銀微粒子コロイド分散液および銀膜
US20090256118A1 (en) * 2005-12-08 2009-10-15 Hiroyuki Tanaka Fine Silver Particle Colloidal Dispersion, Coating Liquid for Silver Film Formation, Processes for Producing These, and Silver Film

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3761590A (en) 1970-05-18 1973-09-25 Research Corp Silver sulfadiazine used in the treatment of burns

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060264518A1 (en) * 2003-04-28 2006-11-23 Kenji Kato Method for preparing liquid colloidal dispersion of silver particles, liquid colloidal dispersion of silver particles, and silver conductive film
US20060090598A1 (en) * 2004-11-03 2006-05-04 Goia Dan V Aqueous-based method for producing ultra-fine silver powders
US20090256118A1 (en) * 2005-12-08 2009-10-15 Hiroyuki Tanaka Fine Silver Particle Colloidal Dispersion, Coating Liquid for Silver Film Formation, Processes for Producing These, and Silver Film
JP2008001961A (ja) * 2006-06-23 2008-01-10 Fujifilm Corp 金属微粒子分散物、着色組成物、感光性転写材料、遮光画像付き基板、カラーフィルタ、及び表示装置
JP2009019235A (ja) * 2007-07-11 2009-01-29 Toda Kogyo Corp 銀ナノ粒子の水性分散液およびその製造方法
JP2009030111A (ja) * 2007-07-27 2009-02-12 Sumitomo Metal Mining Co Ltd 銀微粒子コロイド分散液および銀膜

Also Published As

Publication number Publication date
AP3624A (fr) 2016-03-02
WO2012123924A2 (fr) 2012-09-20
ZA201307018B (en) 2014-05-28
AP2013007143A0 (en) 2013-09-30

Similar Documents

Publication Publication Date Title
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
WO2017030823A3 (fr) Anticorps anti-tigit
WO2014180889A8 (fr) Méthodes et compositions destinées à traiter le cancer
GB201209613D0 (en) New compounds
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
WO2012103038A9 (fr) Compositions de nanoparticules, leurs formulations et leurs utilisations
EP3686200A3 (fr) Composés hétérocycles bicycliques et leurs utilisations en thérapie
PH12015500724A1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
PH12015500713B1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
PH12014502496B1 (en) Bicyclically substituted uracils and the use thereof
EP4414376A3 (fr) Nouveau depsipeptide et ses utilisations
MX2016005668A (es) Formas cristalinas de compuestos terapeuticos y sus usos.
WO2015058664A8 (fr) Utilisation d'icariine pour préparer un médicament destiné à prévenir ou à traiter une baisse des cellules sanguines
WO2015066302A3 (fr) Compositions, méthodes d'utilisation et méthodes de traitement
MX2017015936A (es) Nueva composicion farmaceutica que comprende agentes tensioactivos no ionicos.
WO2016011049A3 (fr) Compositions et procédés pour le traitement de maladies à l'aide de composés distribués sous forme de nanoparticules
WO2014064652A3 (fr) Composition pharmaceutique stable d'interféron pégylé alpha-2b
PH12015502564A1 (en) Pyridone derivatives for the treatment of viral infections and further diseases
WO2013038195A3 (fr) Compositions de nanoparticules pharmaceutiques
WO2013038200A3 (fr) Troubles neurodéveloppementaux
WO2015060702A8 (fr) Composition pharmaceutique pour contrôler la prise de masse corporelle comprenant s-phénotropil
WO2012158776A3 (fr) Thérapie d'association pour le traitement du cancer
HK1228278A1 (en) Crystalline forms of therapeutic compounds and uses thereof
WO2014101294A9 (fr) Composé glycopeptidique ou son sel pharmaceutique et leur procédé de préparation, et compositions pharmaceutiques et applications associées
HK1209111A1 (zh) 醌系化合物及其用於癌症治疗的用途

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12713353

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12713353

Country of ref document: EP

Kind code of ref document: A2